Characterization of the cytokine network at a single cell level in mice with collagen-induced arthritis using a dual color ELISPOT assay

Journal of Interferon and Cytokine Research

Volumn 20, Issue 1, 2000, Pages 55-61

  Okamoto, Yoshihiro ^a   Gotoh, Yoshimitsu ^b   Tokui, Hirotaka ^a   Mizuno, Akira ^a   Kobayashi, Yoshiharu ^c   Nishida, Mikio ^a  

^a MEIJO UNIVERSITY   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON ANTIBODY; INTERLEUKIN 12; INTERLEUKIN 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL MATURATION; CELL POPULATION; CYTOKINE RELEASE; HELPER CELL; LYMPH NODE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN; TH1 CELL; TH2 CELL;

ANIMALS; AUTOIMMUNE DISEASES; CATTLE; COLLAGEN; COLLAGEN DISEASES; COLOR; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; INTERLEUKIN-12; INTERLEUKIN-2; INTERLEUKIN-4; LYMPH NODES; MALE; MICE; MICE, INBRED DBA; ORGAN SPECIFICITY; PERITONEAL CAVITY; SPLEEN; TH1 CELLS; TH2 CELLS;

ANIMALIA;

EID: 0033959881     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/107999000312739     Document Type: Article

References (41)

1. CORTENAY, J.S., DALLMAN, M.J., DAYAN, A.D., MARTIN, A., and MOSEDALE, B. (1980). Immunization against heterogous type II collagen-induced arthritis in mice. Nature 2843, 666-668.
2. TRENTHAM, D.E., TOWNES, A.S., and KANG, A.H. (1977). Autoimmunity to type II collagen: an experimental model of arthritis. J. Exp. Med. 146, 857-868.
3. STUART, J., TOWNES, A., and KANG, A. (1982). The role of collagen autoimmunity in animal models and human diseases. J. Invest. Dermatol. 79(Suppl. 1), 121s-127s.
4. TRENTHAM, D. (1982). Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum. 25, 911-916.
5. STUART, J., CREMER, M., TOWNES, A., and KANG, A. (1982). Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J. Exp. Med. 155, 1-16.
6. WOOLEY, P., LUTHRA, H., KRCO, C., STUART, J., and DAVID, C. (1984). Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum. 27, 1010-1017.
7. TRENTHAM, D., DYNESIUS, R., and DAVID, J. (1978). Passive transfer by cells of type II collagen-induced arthritis in rats. J. Clin. Invest. 62, 359-366.
8. HOLMDAHL, R., KLARESKOG, L., RUBIN, K., LARSSON, E., and WIGZELL, H. (1985). T lymphocytes in collagen II-induced arthritis in mice. Characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand. J. Immunol. 22, 295-306.
9. RANGES, G.E., SRIRAM, S., and COOPER, S.M. (1985). Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med. 162, 1105-1110.
10. CHIOCCHIA, G., BOISSIER, M.C., and FOURNIER, C. (1991). Therapy against murine collagen-induced arthritis with T cell receptor V beta-specific antibodies. Eur. J. Immunol. 21, 2899-2905.
11. OSMAN, G.E., TODA, M., KANAGAWA, O., and HOOD, L.E. (1993). Characterization of the T cell receptor repertoire causing collagen arthritis in mice. J. Exp. Med. 177, 387-395.
12. KAKIMOTO, K., KATSUKI, M., HIROFUJI, T., IWATA, H., and KOGA, T. (1988). Isolation of T cell line capable of protecting mice against collagen-induced arthritis. J. Immunol. 140, 78-83.
13. MOSMANN, T.R., CHERWINSKI, H., BOND, M.W., GIEDLIN, M.A., and COFFMAN, R.L. (1986). Two types of murine helper T-cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136, 2348-2357.
14. + T cell subset with an unrestricted cytokine profile. J. Immunol. 143, 518-525.
15. STREET, N.E., SCHUMACHER, J.H., FONG, T.A.T., BASS, H., FIORENTINO, D.F., LEVERAH, J.A., and MOSMANN, T.R. (1990). Heterogeneity of mouse helper T cell: evidence from bulk cultures and limitating dilution cloning for precursors of Th1 and Th2 cells. J. Immunol. 144, 1629-1639.
16. ABBAS, A.K., MURPHY, K.M., and SHER, A. (1996). Functional diversity of helper T lymphocytes. Nature 383, 787-793.
17. OKAMOTO, Y., ABE, T., NIWA, T., MIZUHASHI, S., and NISHIDA, M. (1998). Development of a dual color enzyme-linked immunospot (ELISPOT) assay for murine T helper type I (Th1)-and T helper type II (Th2)-cells. Immunopharmacology 39, 107-116.
18. ANDO, D., CLAYTON, J., KONO, D., URBAN, J., and SERCARZ, E. (1989). Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol. 124, 132-143.
19. CUA, D., HINTON, D., and STOHLMAN, S. (1995). Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice. Th2-mediated suppression of autoimmune disease. J. Immunol. 155, 4052-4059.
20. KUCHROO, V., DAS, M., BROWN, J., RANGER, A., ZAMVIL, S., SOBEL, R., WEINER, H., NABAVI, N., and GLIMCHER, L. (1995). B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell 80, 707-718.
21. + Th1 and Th2 cells derived from the spleens of diabetic NO mice. J. Clin. Invest. 95, 2979-2985.
22. KATZ, J., BENOIST, C., and MATHIS, D. (1995). T helper cell subsets in insulin-dependent diabetes. Science 268, 1185-1188.
23. BESSIS, N.B.M., FERRARA, P., BLANKENSTEIN, T., FRADELIZI, D., and FOURNIER, C. (1996). Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13. Eur. J. Immunol. 26, 2399-2403.
24. BOISSIER, M., CHIOCCHIA, G., BESSIS, N., HAJNAL, J., GAROTTA, G., NICOLETTI, F., and FOURNIER, C. (1995). Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur. J. Immunol. 25, 1184-1190.
25. NORSFALL, A.C., BUTLER, D.M., MARINOVA, L., WARDEN, P.J., WILLIAMS, R.O., MAINI, R.N., and FELDMANN, M. (1997). Suppression of collagen-induced arthritis by continuous administration of IL-4. Immunol. 159, 5687-5696.
26. MAURITZ, N.J., HOLMDAHL, R., JONSSON, R., VAN DER MEIDE, P.H., SCHEYNIUS, A., and KLARESKOG, L. (1988). Treatment with gamma-interferon triggers the onset of collagen arthritis in mice. Arthritis Rheum. 31, 1297-1304.
27. NAKAJIMA, H., TAKAMORI, H., HIYAMA, Y., and TSUKADA, W. (1990). The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin. Exp. Immunol. 81, 441-445.
28. YOSHINO, S. (1998). Effect of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice. Br. J. Pharmacol. 123, 237-242.
29. MARCELLETTI, J.F., OHARA, J., and KATZ, D.H. (1991). Collagen-induced arthritis in mice. Relationship of collagen-specific and total IgE synthesis to disease. J. Immunol. 147, 4185-4191.
30. SCOTT, P. (1993). IL-12: initiation cytokine for cell-mediated immunity. Science 260, 496-497.
31. + T-cells to enhance priming for interferon-γ production and diminished interleukin-4 inhibition of such priming. Proc. Natl. Acad. Sci. USA 90, 10188-10192.
32. MANETTI, R., PARRONCHI, P., GIUDIZI, M.G., PICCINNI, M.P., MAGGI, E., TRINCHIERI, G., and ROMAGNANI, S. (1993). Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177, 1199-1204.
33. OKAMOTO, Y., MURAKAMI, H., and NISHIDA, M. (1997). Detection of interleukin-6 producing cells among the various organs in normal mice with an improved enzyme-linkd immunospot (ELISPOT) assay. Endocrine J. 44, 349-355.
34. MAURI, C., WILLIAMS, R.O., WALMSLEY, M., and FELDMAN, M. (1996). Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol. 26, 1511-1518.
35. DONCARLI, A., STASIUK, L.M., FOURNIER, C., and ABEHSIRA-AMAR, O. (1997). Conversion in vivo from an early dominant Th0/Th1 response to a Th2 phenotype during the development of collagen-induced arthritis. Eur. J. Immunol. 27, 1451-1458.
36. GERMANN, T., SZELIGA, J., HESS, H., STORKEL, S., PODLASKI, F.J., GATELY, M.K., SCHMITT, E., and RUD, E. (1995). Administration of interleukin 12 in combination with type II collagen induces severe arthritis in DBA/1 mice. Proc. Natl. Acad. Sci. USA 92, 4823-4827.
37. JOOSTEN, L.A., LUBBERTS, E., HELSEN, M.M., and VAN DEN BERG, W.B. (1997). Dual role of IL-12 in early and late stages of murine collagen type II arthritis. J. Immunol. 159, 4094-4102.
38. MA, Y., THORNTON, S., DUWEL, L., BOIVIN, G., GIANNINI, E., LEIDEN, J., BLUESTONE, J., and HIRSCH, R. (1998). Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J. Immunol. 161, 1516-1524.
39. APPARAILLY, F., VERWAERDE, C., JACQUET, C., AURIAULT, C., SANY, J., and JORGENSEN, C. (1998). Adenovirus-mediated transfer of viral IL-10 gene inhibits murine collagen-induced arthritis. J. Immunol. 160, 5213-5220.
40. JOOSTEN, L.A.B., LUBBERTS, E., DUREZ, P., HELSEN, M.M.A., JACOBS, M.J., GOLDMAN, M., and VAN DEN BERG, W.B. (1997). Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis: protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction. Arthritis Rheum. 40, 249-260.
41. WEYAND, C.M., and GORONZY, J.J. (1999). T-cell responses in rheumatoid arthritis: systemic abnormalities - local disease. Curr. Opin. Rheumatol. 11, 210-217.